FR2296430A1 - Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes - Google Patents

Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes

Info

Publication number
FR2296430A1
FR2296430A1 FR7600016A FR7600016A FR2296430A1 FR 2296430 A1 FR2296430 A1 FR 2296430A1 FR 7600016 A FR7600016 A FR 7600016A FR 7600016 A FR7600016 A FR 7600016A FR 2296430 A1 FR2296430 A1 FR 2296430A1
Authority
FR
France
Prior art keywords
prophylactic
pharmaceutical preparations
therapeutic treatment
new pharmaceutical
preparations intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7600016A
Other languages
English (en)
French (fr)
Other versions
FR2296430B1 (cs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2296430A1 publication Critical patent/FR2296430A1/fr
Application granted granted Critical
Publication of FR2296430B1 publication Critical patent/FR2296430B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/625Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7600016A 1975-01-06 1976-01-02 Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes Granted FR2296430A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (2)

Publication Number Publication Date
FR2296430A1 true FR2296430A1 (fr) 1976-07-30
FR2296430B1 FR2296430B1 (cs) 1978-11-10

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600016A Granted FR2296430A1 (fr) 1975-01-06 1976-01-02 Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes

Country Status (14)

Country Link
JP (1) JPS5191337A (cs)
AU (1) AU499140B2 (cs)
BE (1) BE837293A (cs)
CA (1) CA1063516A (cs)
DE (1) DE2600069A1 (cs)
FR (1) FR2296430A1 (cs)
GB (1) GB1510370A (cs)
HK (1) HK49680A (cs)
IE (1) IE42766B1 (cs)
IL (1) IL48785A (cs)
MY (1) MY8100159A (cs)
NL (1) NL7600045A (cs)
NZ (1) NZ179623A (cs)
ZA (2) ZA7628B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (cs) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112248A1 (cs) * 1970-10-02 1972-06-16 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112248A1 (cs) * 1970-10-02 1972-06-16 Ciba Geigy Ag

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
HK49680A (en) 1980-09-12
IE42766L (en) 1976-07-06
ZA7626B (en) 1976-12-29
JPS5191337A (cs) 1976-08-10
IL48785A0 (en) 1976-03-31
IL48785A (en) 1978-08-31
NL7600045A (nl) 1976-07-08
AU499140B2 (en) 1979-04-05
CA1063516A (en) 1979-10-02
ZA7628B (en) 1976-12-29
AU1000276A (en) 1977-07-14
IE42766B1 (en) 1980-10-08
MY8100159A (en) 1981-12-31
BE837293A (fr) 1976-07-05
GB1510370A (en) 1978-05-10
FR2296430B1 (cs) 1978-11-10
NZ179623A (en) 1978-03-06
DE2600069A1 (de) 1976-07-15

Similar Documents

Publication Publication Date Title
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
SE7609316L (sv) Medicinsk inhalationsapparat for behandling av sjukdomar i andningsvegaran
NL188078C (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
FR2313080A1 (fr) Composition topique pour traitement therapeutique et cosmetique et son procede de preparation
BE778334A (fr) Perfectionnements au traitement d'affections de la peau et des muqueuses
FR2325387A1 (fr) Preparations antigeniques et medicament comprenant ces preparations
NO146599C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav
BE857994A (fr) Acides dihydro-oxo-nicotiniques leur preparation et leur application en therapeutique
FR2499407B1 (fr) Composition pharmaceutique et son application therapeutique pour le traitement des maladies de la cavite buccale
FR2289172A1 (fr) Nouvelles amines et leur application au traitement des maladies cardiovasculaires
BE837293A (fr) Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes
BE773121A (fr) Preparations pharmaceutiques destinees au traitement des hyperlipidemies et leur procede d'obtention
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE867396A (fr) Nouveau medicament utile dans le traitement des affections bacteriennes
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
BE809832A (fr) Compositions pharmaceutiques pour le traitement de maladies de la peau
BE837294A (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2308365A2 (fr) Derives de l'hydroxy-9 ellipticine et leur application therapeutique
BE856006A (fr) Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite
NL7605531A (nl) Gedoseerd farmaceutisch preparaat voor de therapie van hyperurikaemie.
BE861326A (fr) Benzisothiazolones pour le traitement prophylactique et therapeutique des affections trombotiques
NL7600511A (nl) Werkwijze voor de bereiding van 2-amino-aceetami- do-(alpha)-fenylbenzylideen-aminoalkanolverbindingen en hun toepassing voor de bereiding van geneesmidde- len.
FR1489M (fr) Diphénlysulfones substituées en 4,4' et leurs préparations pharmaceutiques pour le traitement des maladies virales.
FR2598082B1 (fr) Agent prophylactique et therapeutique de traitement de desordres hepatiques

Legal Events

Date Code Title Description
ST Notification of lapse